Segmed spent the week spotlighting its role as a real-world data and infrastructure partner for medical AI, with a strong presence at the European Congress of Radiology 2026 in Vienna. The company emphasized high-quality, multimodal, de-identified imaging datasets that support AI training, external validation, and regulatory-grade evidence generation.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Segmed showcased research on large language models for CAD-RADS cardiac imaging scoring and reported that an observational study on oligometastatic disease received an ECR research award. This recognition, alongside multiple scientific sessions, underlines the firm’s growing credibility within the radiology and medical imaging AI community.
The company also highlighted a collaboration with iMerit Technology and Advocate Health to build an open-source, annotated 3D mammogram dataset from biopsy-confirmed studies. Reviewed by U.S. board-certified radiologists and enriched with expert lesion segmentations, the dataset is designed to lower barriers to AI research in breast cancer detection.
Beyond research assets, Segmed is leaning into thought leadership via its “Bytes of Innovation” webinars, featuring experts such as Centaur.ai CEO Erik Duhaime and radiologist Martina Aineseder. These sessions focus on topics like collective intelligence in annotation, trustworthy training data, and practical frameworks for building and operationalizing in-house clinical AI programs.
Across its communications, Segmed stressed that AI algorithms are only one part of successful deployment, pointing to data quality, IT integration, workflow alignment, and cross-functional collaboration as critical success factors. This ecosystem-centric stance positions the company less as a pure model vendor and more as a long-term data and implementation partner to hospitals and AI developers.
Looking ahead, Segmed plans continued engagement at major imaging and AI conferences including SAR 2026, ISBI 2026, SIIM 2026, and RSNA 2026. The combination of scientific recognition, ecosystem collaborations, and a focus on responsible, real-world data-driven AI could reinforce Segmed’s competitive position in medical imaging infrastructure and support durable customer relationships.